A Randomized Clinical Trial of Nicotine Preloading for Smoking Cessation in People with Posttraumatic Stress Disorder.

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

Who Took Part

The abstract describes 81 people taking part.

PubMed indexes the participants as adults and middle-aged adults, both men and women.

Participants were recruited from Veterans Affairs outpatient clinics and flyers in the community.

How the Study Was Run

The design is described as randomized, double-blind, placebo-controlled and parallel-group.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Neither the people nor the staff measuring them knew who was on Therapeutic nicotine (patch, non-peptide), so expectations could not easily colour the readings.

The comparison arm used a placebo, so changes seen with Therapeutic nicotine (patch, non-peptide) could be set against what happens without it.

The Therapeutic nicotine (patch, non-peptide) group and the comparison group ran side by side rather than switching.

This was a double-blind parallel randomized controlled trial in 81 people with PTSD who smoked cigarettes.

What Was Measured

The subject headings attached to it are Behavior Therapy, Breath Tests, Cigarette Smoking, Craving, Diagnosis, Dual (Psychiatry), Smoking Cessation and Stress Disorders, Post-Traumatic.

Author keywords: Ecological momentary assessment, nicotine replacement therapy, posttraumatic stress disorder and tobacco.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Therapeutic nicotine (patch, non-peptide) in 81 people.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2018 (Journal of dual diagnosis), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.